ESPE 2018 SATELLITE SYMPOSIUM MEETING REPORT

8 MEETING REPORT – ESPE 2018 SATELLITE SYMPOSIUM Insulin Treatment & Advanced Technology in the Management of Children with Diabetes Summing up, Battelino reiterated the importance of preventing cognitive impairment, and the issue of poor outcomes in females with type 1 diabetes. “I believe it is time to act”. In response to a comment from an audience member, he also emphasised the importance of glycaemic control in even very young children. “No matter how small the child is, we should strive to have the glucose within target or very close to it”. And Chiarelli pointed out that, despite the adverse effects of hypoglycaemia in the very young achieving recent prominence, its effects on the risk for micro- and macrovascular complications was in fact demonstrated in a study published in the 90s. He believes that children should be started on insulin pumps as early as possible, a point with which Battelino concurred. “Whatever it takes: I couldn’t agree more.” * Professor Battelino owns stocks in DreaMed Diabetes. An extract from the Q&A session with Prof Battelino is available here